Travoprost

CAS No. 157283-68-6

Travoprost( Fluprostenol isopropyl ester | AL6221 | Flu-Ipr )

Catalog No. M20546 CAS No. 157283-68-6

Travoprost is used to treat glaucoma and ocular hypertensionis a potent and selective FP prostaglandin receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 77 In Stock
10MG 116 In Stock
25MG 176 In Stock
50MG 255 In Stock
100MG 380 In Stock
500MG 861 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Travoprost
  • Note
    Research use only, not for human use.
  • Brief Description
    Travoprost is used to treat glaucoma and ocular hypertensionis a potent and selective FP prostaglandin receptor agonist.
  • Description
    Travoprost is used to treat glaucoma and ocular hypertensionis a potent and selective FP prostaglandin receptor agonist.(In Vitro):Travoprost has sub-micromolar affinity for the DP, EP1, EP3, EP4, IP, and TP receptors.(In Vivo):Travoprost produces a lower incidence of ocular irritation than PGF20 isopropyl ester at a dose of 1 μg in the New Zealand albino (NZA) rabbit. Topical ocular application of Travoprost produces a marked miotic effect in cats following doses of 0.01, 0.03 and 0.1 μg. In the ocular hypertensive monkey, b.i.d. application of 0.1 and 0.3 μg of travoprost afforded peak reduction in intraocular pressure (IOP) of 22.7% and 28.6%, respectively. Topical application of travoprost was well tolerated in rabbits, cats and monkeys, causing no ocular irritation or discomfort at doses up to 1 μg.
  • In Vitro
    Travoprost has sub-micromolar affinity for the DP, EP1, EP3, EP4, IP, and TP receptors.
  • In Vivo
    Travoprost produces a lower incidence of ocular irritation than PGF20 isopropyl ester at a dose of 1 μg in the New Zealand albino (NZA) rabbit. Topical ocular application of Travoprost produces a marked miotic effect in cats following doses of 0.01, 0.03 and 0.1 μg. In the ocular hypertensive monkey, b.i.d. application of 0.1 and 0.3 μg of travoprost afforded peak reduction in intraocular pressure (IOP) of 22.7% and 28.6%, respectively. Topical application of travoprost was well tolerated in rabbits, cats and monkeys, causing no ocular irritation or discomfort at doses up to 1 μg.
  • Synonyms
    Fluprostenol isopropyl ester | AL6221 | Flu-Ipr
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Prostaglandin Receptor
  • Research Area
    Others
  • Indication
    open-angle glaucoma or ocular hypertension

Chemical Information

  • CAS Number
    157283-68-6
  • Formula Weight
    500.55
  • Molecular Formula
    C26H35F3O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:41.67 mg/mL (83.25 mM)
  • SMILES
    CC(C)OC(=O)CCC\C=C/CC1C(O)CC(O)C1\C=C\C(O)COc1cccc(c1)C(F)(F)F
  • Chemical Name
    propan-2-yl (Z)-7-[(1R2R3R5S)-35-dihydroxy-2-[(E3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hellberg M R Sallee V L Mclaughlin M A et al. Preclinical Efficacy of Travoprost a Potent and Selective FP Prostaglandin Receptor Agonist[J]. Journal of Ocular Pharmacology and Therapeutics 2001 17(5):421-432.
molnova catalog
related products
  • Alprostadil

    Prostaglandin E1 (Alprostadil) is a prostaglandin, which is used in the treatment of erectile dysfunction and has vasodilatory properties.

  • ONO-1301

    A stable, orally active, non-prostanoid prostacyclin I2 (PGI2) mimetic and prostacyclin agonist with inhibitory activity against thromboxane A2 synthase.

  • ASP7657

    ASP7657 (ASP-7657) is a potent, selective, orally active prostaglandin EP4 receptor antagonist with Ki values of 6.02 nM and 2.21 nM for rat and human EP4 receptors, resepctively.